Morgan Stanley’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.4M Buy
977,407
+133,916
+16% +$3.77M ﹤0.01% 2768
2025
Q4
$26.5M Sell
843,491
-183
-0% -$6.07K ﹤0.01% 2667
2025
Q3
$30.1M Buy
843,674
+267,302
+46% +$12.2M ﹤0.01% 2481
2025
Q2
$33.2M Buy
576,372
+54,018
+10% +$3.05M ﹤0.01% 2300
2025
Q1
$30.4M Sell
522,354
-235,046
-31% -$16M ﹤0.01% 2277
2024
Q4
$61M Buy
757,400
+106,627
+16% +$9.11M ﹤0.01% 1657
2024
Q3
$52.1M Buy
650,773
+82,268
+14% +$5.84M ﹤0.01% 1789
2024
Q2
$34.7M Buy
568,505
+262,338
+86% +$15.6M ﹤0.01% 2102
2024
Q1
$15.1M Sell
306,167
-112,679
-27% -$5.36M ﹤0.01% 2980
2023
Q4
$17.6M Buy
418,846
+330,057
+372% +$11.2M ﹤0.01% 3460
2023
Q3
$2.91M Sell
88,789
-34,981
-28% -$1.19M ﹤0.01% 4122
2023
Q2
$4.38M Sell
123,770
-14,559
-11% -$481K ﹤0.01% 3876
2023
Q1
$3.93M Sell
138,329
-6,568
-5% -$232K ﹤0.01% 3969
2022
Q4
$6.02M Buy
144,897
+61,610
+74% +$2.65M ﹤0.01% 3587
2022
Q3
$3.45M Buy
83,287
+26,461
+47% +$1.06M ﹤0.01% 3987
2022
Q2
$1.86M Sell
56,826
-6,753
-11% -$246K ﹤0.01% 4591
2022
Q1
$2.22M Buy
63,579
+24,706
+64% +$595K ﹤0.01% 4436
2021
Q4
$973K Buy
38,873
+38,673
+19,337% +$1.43M ﹤0.01% 5088
2021
Q3
$8K Buy
+200
New +$7.68K ﹤0.01% 7397

Other funds holding PRCT